Davis Polk advised the joint book-running managers in connection with the $80 million public offering of common stock of Dova Pharmaceuticals, Inc. The common stock is…
This content is for Standard 1 Year members only. LoginJoin Now
Author: Ambrogio Visconti
…
This content is for Standard 1 Year members only. LoginJoin Now